Dentsply Sirona Lowers FY2026 Adj EPS Guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 Est; Narrows FY2026 Sales Guidance from $3.500B-$3.600B to $3.500B vs $3.570B Est
Benzinga Newsdesk 2 hours ago
NewsGuidance
Dentsply Sirona (NASDAQ:XRAY) lowers FY2026 Adj EPS guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 analyst estimate. Narrows FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500 billion vs $3.570 billion
Dentsply Sirona (NASDAQ:XRAY) lowers FY2026 Adj EPS guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 analyst estimate. Narrows FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500 billion vs $3.570 billion estimate.